Northwestern Mutual Wealth Management CO Eye Point Pharmaceuticals, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $136 Billion
- Q2 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 1,000 shares of EYPT stock, worth $12,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$12,470
Previous $5,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
162Shares Held
67.2MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$104 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$84.8 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$84.8 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$55.1 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$53.6 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $425M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...